Skeletal muscle contractility and fatigability in adults with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 15, Issue 1, 2016, Pages e1-e8

  Gruet, Mathieu ^a,b,c   Decorte, Nicolas ^a,b   Mely, Laurent ^c,d   Vallier, Jean Marc ^c   Camara, Boubou ^e   Quetant, Sébastien ^e   Wuyam, Bernard ^a,b   Verges, Samuel ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b INSERM   (France)

^c University of Nice Sophia Antipolis   (France)

^d Renée Sabran Hospital   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cystic fibrosis; Exercise tolerance; Neuromuscular fatigue; Skeletal muscle function

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ELECTROMYOGRAPHY; FEMALE; FEMORAL NERVE; HUMAN; ISOMETRIC EXERCISE; MAGNETIC STIMULATION; MALE; MUSCLE CONTRACTILITY; MUSCLE FATIGUE; NERVE STIMULATOR; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; VOLUNTARY MOVEMENT; LUNG DISEASES; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROMYOGRAPHY; FEMALE; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; QUADRICEPS MUSCLE; SEVERITY OF ILLNESS INDEX;

EID: 84959557828     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.05.004     Document Type: Article

References (32)

1. Hebestreit H, Schmid K, Kieser S, Junge S, Ballmann M, Roth K, et al. Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulm Med; in press. doi: 10.1186/1471-2466-14-26:14-26.
2. Pianosi P., Leblanc J., Almudevar A. Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005, 60:50-54.
3. Hulzebos E.H., Bomhof-Roordink H., van de Weert-van Leeuwen P.B., Twisk J.W., Arets H.G., van der Ent C.K., et al. Prediction of mortality in adolescents with cystic fibrosis. Med Sci Sports Exerc 2014, 46:2047-2052.
4. Dodd J.D., Barry S.C., Daly L.E., Gallagher C.G. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibros 2005, 4:101-105.
5. Sahlberg M.E., Svantesson U., Thomas E.M., Strandvik B. Muscular strength and function in patients with cystic fibrosis. Chest 2005, 127:1587-1592.
6. Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009, 33:99-106.
7. de Meer K., Gulmans V.A., van Der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999, 159:748-754.
8. Sahlberg M., Svantesson U., Magnusson Thomas E., Andersson B.A., Saltin B., Strandvik B. Muscular strength after different types of training in physically active patients with cystic fibrosis. Scand J Med Sci Sports 2008, 18:756-764.
9. Wells G.D., Wilkes D.L., Schneiderman J.E., Rayner T., Elmi M., Selvadurai H., et al. Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 2011, 69:40-45.
10. Lamhonwah A.M., Bear C.E., Huan L.J., Kim Chiaw P., Ackerley C.A., Tein I. Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 2010, 67:802-808.
11. Bachasson D., Millet G.Y., Decorte N., Wuyam B., Levy P., Verges S. Quadriceps function assessment using an incremental test and magnetic neurostimulation: a reliability study. J Electromyogr Kinesiol 2013, 23:649-658.
12. Bachasson D., Guinot M., Wuyam B., Favre-Juvin A., Millet G.Y., Levy P., et al. Neuromuscular fatigue and exercise capacity in fibromyalgia syndrome. Arthritis Care Res 2013, 65:432-440.
13. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
14. Henry B., Aussage P., Grosskopf C., Goehrs J.M. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 2003, 12:63-76.
15. Verges S., Maffiuletti N.A., Kerherve H., Decorte N., Wuyam B., Millet G.Y. Comparison of electrical and magnetic stimulations to assess quadriceps muscle function. J Appl Physiol 2009, 106:701-710.
16. Hussey J., Gormley J., Leen G., Greally P. Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros 2002, 1:116-121.
17. Dufresne V., Knoop C., Van Muylem A., Malfroot A., Lamotte M., Opdekamp C., et al. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis. Am J Respir Crit Care Med 2009, 180:153-158.
18. Barry S.C., Gallagher C.G. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 2003, 95:1379-1384.
19. Burtin C., Van Remoortel H., Vrijsen B., Langer D., Colpaert K., Gosselink R., et al. Impact of exacerbations of cystic fibrosis on muscle strength. Respir Res 2013, 14:46.
20. Augarten A., Paret G., Avneri I., Akons H., Aviram M., Bentur L., et al. Systemic inflammatory mediators and cystic fibrosis genotype. Clin Exp Med 2004, 4:99-102.
21. Gruet M., Vallier J.M., Mely L., Brisswalter J. Long term reliability of EMG measurements in adults with cystic fibrosis. J Electromyogr Kinesiol 2010, 20:305-312.
22. Hill C.A., Thompson M.W., Ruell P.A., Thom J.M., White M.J. Sarcoplasmic reticulum function and muscle contractile character following fatiguing exercise in humans. J Physiol 2001, 531:871-878.
23. Place N., Bruton J.D., Westerblad H. Mechanisms of fatigue induced by isometric contractions in exercising humans and in mouse isolated single muscle fibres. Clin Exp Pharmacol Physiol 2009, 36:334-339.
24. Dodd J.W., Chung A.W., van den Broek M.D., Barrick T.R., Charlton R.A., Jones P.W. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012, 186:240-245.
25. Alexandre F, Heraud N, Oliver N, Varray A. Cortical implication in lower voluntary muscle force production in non-hypoxemic COPD patients. PLoS ONE; in press. doi: 10.1371/journal.pone.0100961. eCollection 2014.
26. Vivodtzev I., Decorte N., Wuyam B., Gonnet N., Durieu I., Levy P., et al. Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest 2013, 143:485-493.
27. Fogarty A.W., Britton J., Clayton A., Smyth A.R. Are measures of body habitus associated with mortality in cystic fibrosis?. Chest 2012, 142:712-717.
28. Selvadurai H.C., McKay K.O., Blimkie C.J., Cooper P.J., Mellis C.M., Van Asperen P.P. The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002, 165:762-765.
29. Divangahi M., Balghi H., Danialou G., Comtois A.S., Demoule A., Ernest S., et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009, 5:e1000586.
30. Savi D., Quattrucci S., Internullo M., De Biase R.V., Calverley P.M., Palange P. Measuring habitual physical activity in adults with cystic fibrosis. Respir Med 2013, 107:1888-1894.
31. Philippaerts R.M., Westerterp K.R., Lefevre J. Doubly labelled water validation of three physical activity questionnaires. Int J Sports Med 1999, 20:284-289.
32. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006, 27:1040-1055.